Associations of progesterone receptor polymorphisms with age at menarche and menstrual cycle length

Hormone Research in Paediatrics

Volumn 74, Issue 6, 2010, Pages 421-427

  Taylor, K C ^a   Small, C M ^a   Epstein, M P ^b   Sherman, S L ^b   Tang, W ^a   Wilson, M M ^a   Bouzyk, M ^a   Marcus, M ^a  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Age at menarche; Menstrual cycles; Polymorphism; Progesterone receptor; Reproductive cancers

Indexed keywords

PROGESTERONE RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FERTILITY; GENE LINKAGE DISEQUILIBRIUM; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; MENSTRUAL CYCLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELF REPORT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE FACTORS; DNA; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; MENARCHE; MENSTRUAL CYCLE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, PROGESTERONE; REGRESSION ANALYSIS; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 78650515364     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000316961     Document Type: Article

References (30)

1. Guo Y, Shen H, Xiao P, Xiong DH, Yang TL, Guo YF, Long JR, Recker RR, Deng HW: Genomewide linkage scan for quantitative trait loci underlying variation in age at menarche. J Clin Endocrinol Metab 2006;91:1009-1014.
2. Towne B, Czerwinski SA, Demerath EW, Blangero J, Roche AF, Siervogel RM: Heritability of age at menarche in girls from the Fels Longitudinal Study. Am J Phys Anthropol 2005;128:210-219.
3. Taylor KC, Small CM, Epstein MP, Terrell ML, Marcus M: Heritability of age at menarche and menstrual cycle length in a population exposed to a brominated flame retardant. Int J Child Adolescent Health 2009;2:383-394.
4. Leite DB, Junqueira MG, de Carvalho CV, Massad-Costa AM, Gonçalves WJ, Nicolau SM, Lopes LA, Baracat EC, da Silva ID: Progesterone receptor (PROGINS) polymorphism and the risk of ovarian cancer. Steroids 2008;73:676-680.
5. Johnatty SE, Spurdle AB, Beesley J, Chen X, Hopper JL, Duffy DL, Chenevix-Trench G: Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies. Breast Cancer Res Treat 2008;109:91-99.
6. Wang-Gohrke S, Chang-Claude J, Becher H, Kieback DG, Runnebaum IB: Progesterone receptor gene polymorphism is associated with decreased risk for breast cancer by age 50. Cancer Res 2000;60:2348-2350.
7. De Vivo I, Huggins GS, Hankinson SE, Lescault PJ, Boezen M, Colditz GA, Hunter DJ: A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk. PNAS 2002;99:12263-12268.
8. Romano A, Lindsey PJ, Fischer D-C, Delvoux B, Paulussen AD, Janssen RG, Kieback DG: Two functionally relevant polymorphisms in the human progesterone receptor gene (+331 G/A and progins) and the predisposition for breast and/or ovarian cancer. Gynecol Oncol 2006;101:287-295.
9. Pooley KA, Healey CS, Smith PL, Pharoah PDP, Thompson D, Tee L, West J, Jordan C, Easton DF, Ponder BAJ, Dunning AM: Association of the progesterone receptor gene with breast cancer risk: a single-nucleotide polymorphism tagging approach. Cancer Epidemiol Biomarkers Prevention 2006;15:675-682.
10. Romano A, Delvoux B, Fischer D-C, Groothuis P: The PROGINS polymorphism of the human progesterone receptor diminishes the response to progesterone. J Mol Endocrinol 2007;38:331-350.
11. Terry KL, De Vivo I, Titus-Ernstoff L, Sluss PM, Cramer DW: Genetic variation in the progesterone receptor gene and ovarian cancer risk. Am J Epidemiol 2005;161:442-451.
12. Schweikert A, Rau T, Berkholz A, Allera A, Daufeldt S, Wildt L: Association of progesterone receptor polymorphism with recurrent abortions. Eur J Obstet Gynecol Reprod Biol 2004;113:67-72.
13. Jabbour HN, Kelly RW, Fraser HM, Critchley HOD: Endocrine regulation of menstruation. Endocr Rev 2006;27:17-46.
14. Marcus M, Gerr F: Upper extremity musculoskeletal symptoms among female office workers: associations with video display terminal use and occupational psychosocial stressors. Am J Ind Med 1996;29:161-170.
15. The International HapMap Consortium: The International HapMap Project. Nature 2003;426:789-796.
16. Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265.
17. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D: Efficiency and power in genetic association studies. Nat Genet 2005;37:1217-1223.
18. Beckman Coulter, Inc: Genome Lab SNPStream Genotyping System 48-plex Training Guide. Fullerton, Beckman Coulter, 2005.
19. Wigginton JE, Cutler DJ, Abecasis GR: A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 2005;76:887-893.
20. Tam CS, de Zegher F, Garnett SP, Baur LA, Cowell CT: Opposing influences of prenatal and postnatal growth on the timing of menarche. J Clin Endocrinol Metab 2006;91:4369-4373.
21. Frisch RE, McArthur JW: Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science 1974;185:949-951.
22. Maclure M, Travis LB, Willett W, MacMahon B: A prospective cohort study of nutrient intake and age at menarche. Am J Clin Nutr 1991;54:649-656.
23. Kwee LC, Liu D, Lin X, Ghosh D, Epstein MP: A powerful and flexible multilocus association test for quantitative traits. Am J Hum Genet 2008;82:386-397.
24. Stikkelbroeck NMML, Sweep CGJ, Braat DDM, Hermus ARMM, Otten BJ: Monitoring of menstrual cycles, ovulation, and adrenal suppression by saliva sampling in female patients with 21-hydroxylase deficiency. Fertil Steril 2003;80:1030-1036.
25. Agoulnik IU, Tong XW, Fischer DC, Körner K, Atkinson NE, Edwards DP, Headon DR, Weigel NL, Kieback DG: A germline variation in the progesterone receptor gene increases transcriptional activity and may modify ovarian cancer risk. J Clin Endocrinol Metab 2004;89:6340-6347.
26. Breast Cancer Association Consortium: Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. J Natl Cancer Inst 2006;98:1382-1396.
27. Pearce CL, Wu AH, Gayther SA, et al: Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the ovarian cancer association consortium pooled analysis. Br J Cancer 2008;98:282-288.
28. Paynter RA, Skibola DR, Skibola CF, Buffler PA, Wiemels JL, Smith MT: Accuracy of multiplexed illumina platform-based singlenucleotide polymorphism genotyping compared between genomic and whole genome amplified DNA collected from multiple sources. Cancer Epidemiol Biomarkers Prev 2006;15:2533-2536.
29. van der Hel OL, van der Luijt RB, Bas Bueno de Mesquita H, van Noord PAH, Slothouber B, Roest M, van der Schouw YT, Grobbee DE, Pearson PL, Peeters PHM: Quality and quantity of DNA isolated from frozen urine in population-based research. Analyt Biochem 2002;304:206-211.
30. McDowell MA, Brody DJ, Hughes JP: Has age at menarche changed? Results from the National Health and Nutrition Examination Survey (NHANES) 1999-2004. J Adolesc Health 2007;40:227-231